Quick Facts
- Best For: Patients seeking advanced cancer therapies (proton therapy, CAR-T, immunotherapy) at 40-70% lower cost than the USA.
- Estimated Cost: $15,000 - $120,000 USD depending on cancer type and treatment protocol.
- Cost Savings: 40-70% vs. USA; 30-50% vs. Europe.
- Top Oncology Hospitals: Fudan University Shanghai Cancer Center, Chinese Academy of Medical Sciences Cancer Hospital (Beijing), Sun Yat-sen University Cancer Center (Guangzhou), West China Hospital (Chengdu), Shanghai Proton & Heavy Ion Center.
- Key Treatments Available: Surgery, chemotherapy, radiation therapy, proton/heavy ion therapy, CAR-T cell therapy, PD-1/PD-L1 immunotherapy, targeted therapy, clinical trials.
- Average Stay: 2-8 weeks depending on treatment type.
- Language Support: English available at all major oncology centers listed below.
Introduction
China has rapidly advanced its oncology capabilities to become one of the world's leading destinations for cancer treatment. With the National Cancer Center reporting over 4.8 million new cancer diagnoses annually in China, the sheer scale of clinical experience at top Chinese hospitals is unmatched by most countries. This high patient volume translates into deep expertise, particularly for cancers that are common in East Asia such as liver, gastric, nasopharyngeal, and lung cancer.
For international patients, China offers a compelling combination: access to world-class oncology specialists and cutting-edge treatments — including therapies that may be unavailable or prohibitively expensive elsewhere — at significantly lower costs. This guide covers the major cancer treatment modalities available in China, identifies the top hospitals, breaks down costs, and provides practical guidance for medical tourists.
Available Cancer Treatment Modalities
Surgery
Surgical oncology in China benefits from high case volumes and rapid adoption of minimally invasive techniques. Robotic surgery platforms (Da Vinci, Toumai, and MicroHand systems) are widely available at leading centers. Key strengths include:
- Hepatocellular carcinoma (liver cancer): China performs more liver cancer surgeries than any other country. Surgeons at institutions like the Eastern Hepatobiliary Surgery Hospital (Shanghai) have decades of experience with complex hepatectomies.
- Gastric cancer: Minimally invasive gastrectomy with D2 lymph node dissection is routinely performed, with outcomes comparable to Japan and South Korea.
- Lung cancer: Video-assisted thoracoscopic surgery (VATS) and robotic-assisted lobectomy are standard at top centers.
Proton and Heavy Ion Therapy
China is expanding its particle therapy network quickly. The Shanghai Proton & Heavy Ion Center (SPHIC) is one of the world's most experienced facilities, having treated over 5,000 patients since opening. Particle therapy is particularly effective for:
- Skull base and brain tumors
- Pediatric cancers (minimizing radiation exposure to developing organs)
- Hepatocellular carcinoma
- Locally advanced pancreatic cancer
- Head and neck tumors near critical structures
Additional proton therapy centers are operational or under construction in Shandong, Gansu (Lanzhou Institute of Modern Physics), and Guangzhou.
CAR-T Cell Therapy
China is a global leader in CAR-T cell therapy, with multiple NMPA-approved products and hundreds of active clinical trials. Approved CAR-T products include:
- Yescarta (axicabtagene ciloleucel) — for relapsed/refractory large B-cell lymphoma
- Carteyva (relmacabtagene autoleucel) — domestically developed by JW Therapeutics
- Fucaso (equecabtagene autoleucel) — the world's first approved BCMA-targeting CAR-T for multiple myeloma
CAR-T therapy in China costs approximately $50,000-$120,000 USD, compared to $373,000-$475,000 in the USA — representing savings of 70-85%.
Immunotherapy (Checkpoint Inhibitors)
China has approved multiple PD-1 and PD-L1 checkpoint inhibitors, both international and domestically developed:
- Keytruda (pembrolizumab) and Opdivo (nivolumab) — available for multiple indications
- Tyvyt (sintilimab), Tuoyi (toripalimab), Camrelizumab — domestically developed alternatives at lower cost
Chinese-developed immunotherapies can cost 50-80% less than their Western equivalents while demonstrating comparable efficacy in clinical trials.
Targeted Therapy and Precision Medicine
Genomic profiling and targeted therapy are routine at top Chinese cancer centers. Institutions like Fudan University Shanghai Cancer Center and the National Cancer Center (Beijing) offer comprehensive genomic testing panels that identify actionable mutations, enabling personalized treatment selection with tyrosine kinase inhibitors (TKIs), PARP inhibitors, and other targeted agents.
Clinical Trials
China is the world's second-largest source of oncology clinical trials after the United States. International patients may be eligible for trials offering access to investigational drugs not yet available commercially. Key trial hubs include Beijing, Shanghai, Guangzhou, and the Boao Lecheng International Medical Tourism Zone in Hainan (which has special approval for early-access drugs).
Top Oncology Hospitals
1. Fudan University Shanghai Cancer Center
China's largest specialized cancer hospital, treating over 160,000 patients annually. Strengths include breast cancer, colorectal cancer, and gynecologic oncology. Features comprehensive genomic profiling, multidisciplinary tumor boards, and an international patient department.
2. Chinese Academy of Medical Sciences Cancer Hospital, Beijing
The national reference center for cancer treatment and research. Known for its leadership in esophageal cancer, lung cancer, and lymphoma. Home to the National Cancer Center of China, providing access to the latest clinical trials and treatment protocols.
3. Sun Yat-sen University Cancer Center, Guangzhou
One of Asia's largest dedicated cancer centers, nationally ranked for nasopharyngeal carcinoma, liver cancer, and hematological malignancies. Pioneered several chemoradiation protocols now adopted internationally. Comprehensive international patient services.
4. Shanghai Proton & Heavy Ion Center (SPHIC)
China's premier particle therapy facility, equipped with proton and carbon-ion treatment systems. Has treated 5,000+ patients with published outcomes comparable to leading centers in Japan and Germany. Dedicated to oncology radiation therapy.
5. West China Hospital, Sichuan University, Chengdu
Top 3 nationally ranked comprehensive hospital with an extensive oncology department. Strong in lung, esophageal, and hepatobiliary cancers. Features a large clinical trial network and robotic surgery program.
Cost Breakdown
| Treatment | China (USD) | USA (USD) | Savings |
|---|---|---|---|
| Lung cancer lobectomy (robotic) | $10,000 - $18,000 | $30,000 - $60,000 | 60-70% |
| Proton therapy (full course) | $30,000 - $50,000 | $80,000 - $150,000 | 55-65% |
| CAR-T cell therapy | $50,000 - $120,000 | $373,000 - $475,000 | 70-85% |
| PD-1 immunotherapy (per year) | $8,000 - $20,000 | $100,000 - $200,000 | 85-92% |
| Comprehensive genomic profiling | $800 - $2,000 | $3,000 - $8,000 | 70-75% |
| Liver cancer hepatectomy | $8,000 - $15,000 | $25,000 - $50,000 | 60-70% |
| Accommodation (per week) | $200 - $600 | $500 - $2,000 | 60-70% |
Costs are estimates and may vary. Contact hospitals directly for personalized quotes.
What International Patients Should Know
Multidisciplinary Tumor Boards
All major Chinese cancer hospitals operate multidisciplinary tumor boards (MDTs) where surgeons, medical oncologists, radiation oncologists, pathologists, and radiologists collectively discuss each patient's case. International patients can request MDT review.
Second Opinions
Before traveling, you can submit medical records for remote assessment. Most top hospitals offer telemedicine consultations where Chinese specialists can review prior imaging, pathology reports, and treatment history.
Bringing Prior Records
Bring all relevant medical records, imaging (ideally on CD/USB with DICOM format), pathology slides for re-review, and a complete medication list. Having records translated into Chinese or English (if in another language) will accelerate the process.
Follow-up Care
Discuss post-treatment follow-up before you leave. Many hospitals offer remote monitoring and coordination with your oncologist at home. For treatments like CAR-T therapy, a minimum 4-week post-infusion monitoring stay is typically required.
Frequently Asked Questions
Q: What types of cancer are Chinese hospitals most experienced with? A: Lung, liver, gastric, esophageal, nasopharyngeal, and colorectal cancers — due to high incidence rates in China. However, top centers also treat all other cancer types with world-class expertise.
Q: Can I access CAR-T therapy in China if I've been denied in my home country? A: Possibly. China's clinical trial landscape for CAR-T is among the most active globally, and eligibility criteria may differ. Contact hospitals directly to discuss your specific situation.
Q: Is proton therapy available for all cancer types? A: Proton therapy is most effective for localized solid tumors, especially those near radiation-sensitive structures. It is not indicated for all cancers. Your radiation oncologist will determine suitability.
Q: How do I verify a hospital's credentials? A: Look for Grade III-A certification (China's highest hospital tier), JCI accreditation (where applicable), and membership in the China Anti-Cancer Association. Published outcomes data and clinical trial registrations (at clinicaltrials.gov) are also strong indicators of quality.
Q: What about post-treatment surveillance? A: Top hospitals will create a follow-up schedule and coordinate with your medical team at home. Many offer telemedicine follow-ups for international patients.
How to Get Started
- Gather your medical records — including pathology reports, imaging (DICOM format preferred), treatment history, and current medications.
- Choose a hospital — select based on your cancer type, desired treatment modality, and the hospital's specific strengths.
- Submit records for pre-assessment — most hospitals accept records electronically for preliminary review and cost estimates.
- Schedule a telemedicine consultation — discuss your case with the treating physician before committing to travel.
- Arrange travel and visa — apply for a medical visa with documentation from the hospital.
Medical Disclaimer
This article provides general information about cancer treatment options in China and is not intended as medical advice. Cancer treatment outcomes depend on multiple factors including cancer type, stage, patient health, and specific treatment protocols. Success rates cited are based on published institutional data and clinical trial results. Always consult with qualified oncologists before making treatment decisions. This information does not constitute an endorsement of any specific treatment or institution.